Virus Geeks Burlingame

Theravance is a biopharmaceutical company that focuses on the discovery, development and commercialization of small molecule medicines. It develops drugs for various therapeutic areas, including respiratory diseases, bacterial infections and gastrointestinal motility dysfunctions. The company emphasizes drug discovery on validated targets. Some of its research programs include telavancin, Bifunctional Muscarinic Antagonist-beta2 Agonist (MABA) and Horizon. It works in association with some of the leading pharmaceutical companies, such as Astellas Pharma, Bristol-Myers Squibb Company, Gilead Sciences, ICOS Corporation, Merck & Company, Millennium Pharmaceuticals, Pfizer and GlaxoSmithKline. Theravance additionally conducts various phases of clinical trails on animals to test the efficacy of drugs.

Traycer Diagnostic Systems, Inc is a cutting-edge company based in Burlingame, CA that specializes in providing innovative diagnostic solutions. With a focus on advanced technology and research, Traycer Diagnostic Systems, Inc offers a range of diagnostic services to meet the needs of various industries. By leveraging their expertise and state-of-the-art equipment, Traycer Diagnostic Systems, Inc aims to deliver accurate and reliable results for their clients. Committed to excellence, the company continues to push the boundaries of diagnostic testing to enhance outcomes and drive progress in the field. Generated from their business information

Percipio Biosciences Inc., located in Burlingame, CA, is at the forefront of glycobiology research, focusing on the intricate roles of carbohydrates in biological systems. The company is dedicated to advancing personalized therapies through innovative glycan profiling and evaluation techniques. With a strong emphasis on glycosylation and its impact on various therapeutic applications, Percipio Biosciences is pioneering developments in vaccine engineering and biomanufacturing. Their research aims to optimize therapeutic efficacy and improve drug discovery processes by harnessing the potential of glycan-protein interactions. Generated from the website